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Two of the top four causes of death worldwide, heart disease and stroke, are related to 
hyperlipidemia, elevated cholesterol levels; these two illnesses account for approximately 
seventeen million deaths each year (World Health Organization, 2014). In order to combat the 
prevalence of these illnesses, the National Cholesterol Educational Panel has issued guidelines 
regarding cholesterol management. Extensive research has been published concerning 
cholesterol management. However, a gap remains between evidenced-based practice and 
community awareness of this phenomenon. This manuscript compiles research from peer- 
reviewed nursing journals and acclaimed government and national organizations to express the 
cause, effect, and control of hyperlipidemia while identifying prevention strategies to decrease 
the incidence and prevalence of hyperlipidemia. 
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An Analysis of the Cause, Effect, and Control of Hyperlipidemia 
Worldwide cardiovascular disease has posed a major threat to health; in fact, it remains 
the leading cause of death among men and women regardless of race or ethnicity (Dembowski & 
Davidson, 2009). Approximately 53% of adults in the United States of America suffer from 
hyperlipidemia, also known as hypercholestremia; furthermore, hyperlipidemia accounts for 
more than four million deaths globally (Joffres, Shields, Tremblay, & Connor Gorber, 2013). In 
fact, nearly 62% of individuals in their fifties suffer from hyperlipidemia (National Institute of 
Health, 2012). Reducing cholesterol levels is the primary intervention in decreasing the 
occurrence of cardiovascular disease, a classification for diseases of the blood vessels and/ or 
heart (Dembowski & Davidson, 2009). This manuscript analyzes the cause, effect, and control 
of hyperlipidemia while identifying prevention strategies to decrease the incidence and 
prevalence of hyperlipidemia worldwide. 
What is Hyperlipidemia? 
Hyperlipidemia is an elevation of low-density lipoproteins and/or decrease in high- 
density lipoproteins within the body, determining an individual's cholesterol level. Cholesterol 
is a fatty compound synthesized in the liver and found in animal tissues (Cholesterol, 2013; 
National Institute of Health, 2012). Cholesterol performs a variety of functions throughout the 
body which include: "building and maintaining cell membranes; assisting in the manufacture of 
androgens, estrogens, and aldosterone; aiding in the production of bile; assisting the synthesis of 
vitamin D; helping metabolize fat-soluble vitamins; and insulating nerve fibers" (Murphy, 2011, 
p. 1). However, the human body is incapable of efficiently breaking down cholesterol into a 
usable form of energy; therefore, it has no caloric value (Dudek, 2010). 
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Lipoproteins transport cholesterol to the body tissue to preserve body functions and to the 
liver for excretion; lipoproteins are divided into two categories: low-density lipoproteins and 
high density- lipoproteins (Thorton-Miller, 2008). In order to determine one's total cholesterol 
level, the amount of high-density lipoproteins is calculated in addition to the amount of low- 
density lipoproteins with 20% of the triglyceride level (American Heart Association, 2013a). 
Ideally, this calculation should be less than 200 milligrams per deciliter (American Heart 
Association, 2013a). 
The body utilizes high-density lipoproteins to carry the low-density lipoproteins to the 
liver in order to excrete low-density lipoproteins out of the body on a daily basis, preserving 
healthy bodily functions (American Heart Association, 2013a). Low-density lipoproteins 
transport cholesterol molecules to the body's tissue. Unfortunately, low-density lipoproteins may 
also act as a barrier to the blood vessels. It is widely recognized that triglycerides are the most 
prevalent lipid found within the body. The collection of these lipoproteins results in an 
accumulation of fatty plaque, which is known as atherosclerosis (Cholesterol, 2013). 
Triglycerides can accelerate the development of atherosclerosis (American Heart Association, 
2013a). As a result, the vessels become obstructed and hardened, eventually scaring the tissue, 
which narrows the vessels and prevents efficient circulation of blood and vital nutrients 
throughout the body. Additionally, "... [cholesterol] is associated with enhanced expression of 
proinflammatory mechanisms leading to increased levels of proinflammatory cytokines, cellular 
adhesion molecules and inflammation sensitive plasma proteins" (Ramaraju, Krishnamurthy, 
Maamidi, Kaza, & Balasubramaniam, 2013, p. 295). 
Ideally, low-density lipoproteins should be restricted to 130 milligrams per deciliter 
(mg/dL), high-density lipoproteins should be greater than 60 mg/dL, and triglycerides should be 
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limited to 150 mg/dL to prevent atherosclerosis (Woods, 2010). The process of balancing 
lipoproteins is constantly stimulating various bodily functions while maintaining homeostasis; 
unfortunately, there are instances when this system becomes weakened and/or fails. In these 
circumstances, patients develop hyperlipidemia, sometimes referred to as dyslipidemia or 
hypercholesterolemia. These terms are defined as an elevation of low-density lipoproteins 
and/or decrease in high-density lipoproteins within the body. 
Hyperlipidemia Awareness 
The importance of primary prevention methods cannot be over-emphasized, when 
endeavoring to effectively reduce the number of deaths related to hyperlipidemia and enhance 
the health of the population. Often, individuals become ill because they are unaware of how, and 
to what extent, their lifestyle affects their health. Most often, when people hear the terminology 
cholesterol, they habitually presume that it is hazardous to their health. Others tend to disregard 
the importance of cholesterol measurement altogether since it is not directly visible on a weight 
scale. It is important to educate these individuals on the delicate balance that must be maintained 
between high-density lipoproteins and low-density lipoproteins as opposed to eliminating 
cholesterol from the diet or underestimating the effects that abnormal cholesterol levels have on 
the body. 
Risk Factors 
In addition to promoting primary prevention methods, secondary prevention is necessary in order 
to encourage early intervention to prevent further progression of the disease process. Health 
screenings are performed to identify a patient's risk for illness or disease; the screening, for 
hyperlipidemia, should include the patient's height, weight, age, body mass index, blood 
pressure, total cholesterol, triglycerides, and high-density lipoprotein levels (Potera, 2010). 
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Obesity, peripheral artery disease, and an inactive lifestyle can greatly increase a patient's risk 
for hyperlipidemia (Mayo Clinic, 2013). In addition, a family history of heart disease, diabetes, 
and/or hypertension are risk factors for heart disease (Potera, 2010). Lifestyle behaviors such as 
smoking or sleeping less than six hours per day can alter normal cholesterol values as well 
(Mayo Clinic, 2013; Mosca & Aggarwal, 2012). Essentially, genetics determine approximately 
30% to 60% of the low-density lipoprotein particle size; the remainder is based on lifestyle 
behaviors (Thorton-Miller, 2008). 
Not only are there risk factors for hypercholestremia, but also hypercholestremia serves 
as a risk factor for other severe conditions. In fact, hypercholestremia has been linked to heart 
disease and stroke, two of the top four causes of death in America; therefore, management of 
cholesterol is of the utmost importance when attempting to reduce these numbers and save lives 
(Griffin, 2012). According to Oguejiofor, Onwukwe, and Odenigbo (2012) "...dyslipidemia 
accounted for 18% of ischemic heart disease, 56% of stroke, and more than 4 million deaths per 
year globally" (p. 198). The increased incidence of hemorrhagic stroke suggests that 
maintaining low-density lipoproteins levels at 100 mg/dL may be a safe target for individuals at 
risk of cerebrovascular events (Schwertz & Badellino, 2008). In addition, hypercholestremia has 
been identified as a risk factor for Parkinson's disease in individuals between the age of 25 and 
54-years-old (Macready, 2009). Because of its inflammatory properties, hypercholestremia has 
been linked as a risk factor for asthma, an inflammation of the airway passages, but once a 
patient is diagnosed with asthma, research shows that cholesterol levels have no effect on the 
disease process (Ramaraju et al., 2013). However, merely a decline by one milligram per 
deciliter in low-density lipoprotein concentration can decrease one's risk for a cardiovascular 




In addition, the production of estrogen has been linked to increasing levels of high- 
density lipoproteins within the body, which have beneficial effects on the body (American Heart 
Association, 2013b). After menopause, women's estrogen levels begin to decline, decreasing its 
protecting capabilities; therefore, older women have an increased risk for hyperlipidemia. In 
pregnant women, Dey, Arora, Narayan, and Kumar (2013) suggested that hyperlipidemia is a 
risk factor for pre-eclampsia; therefore, they recommended having a lipid profile completed at 8 
to 20 weeks of gestation to encourage pro-active treatment for pre-eclampsia. Regardless of age, 
cardiovascular disease remains the number one cause of death in women; therefore, education is 
vital in reducing the incidence and prevalence of this devastating disease. Caboral (2013) 
reported that in a study of 2,300 women that only 54% of the sample identified cardiovascular 
disease as the leading cause of death in women. Often, hyperlipidemia is associated with men; 
however, it affects men and women alike. In fact, in 2008, 7% more deaths occurred in women 
than men following a heart attack (Caboral, 2013). Therefore, it should be emphasized to health 
care professionals that there is a similar need to assess females for hyperlipidemia as well. 
Assessment 
"The major difficulty in treating dyslipidemia is detection" (O'Donovan, Sahm, Shannon, 
& Byrne, 2011, p. 22). Hyperlipidemia yields no symptoms unless damage to an organ system 
has occurred (Griffin, 2012). Although hyperlipidemia lacks symptoms, it is important to 
recognize the symptoms when the body is in distress. In men, a heart attack typically presents 
with chest pain; however, in women, more subtle signs occur, such as shortness of breath, 
diaphoresis, epigastric pain, and fatigue (Caboral, 2013). Comparatively, men are assessed and 
treated for these symptoms more frequently than women, which displays a slight bias in the 
medical field; furthermore, this bias carries over into the research field where studies are 
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conducted with predominantly male populations (Caboral, 2013). A health care provider should 
ensure that each patient receives the proper care needed by eliminating this disparity, 
encouraging a reduction in the death of women and men with heart disease alike. Furthermore, 
Macready (2009) reported that a sudden decrease in total cholesterol concentration may be an 
indication of imminent Alzheimer's disease or Parkinson's disease. 
Mayo Clinic (2012) stated there are no symptoms associated with hyperlipidemia. 
Nevertheless, researchers have found a few similarities among patients that may be indicative of 
hyperlipidemia. For example, Mosca and Aggarwal (2012) concluded that, "snoring was a 
significant predictor of low high-density lipoprotein cholesterol level regardless of gender or 
ethnicity and was likely mediated by obesity" (p. 266).   Although snoring may be a subtle 
indicator used to identify a hyperlipidemic patient before organ damage has occurred, this is not 
an infallible sign. Nevertheless, any abnormal symptoms should not be disregarded. The health 
care provider should be notified in order to complete a focused assessment. 
Analysis 
Since hyperlipidemia presents no symptoms before it damages the body, screening is 
paramount when education is ineffective or sparsely available. "The widely accepted National 
Cholesterol Education Program (NCEP) guidelines recommend measuring lipid concentrations 
every 5 years when cardiovascular risk factors are absent and every year when any 
cardiovascular risk factor is present" (Mendez-Gonzalez, Bonet-Marques & Ordonez-Llanos, 
2010, p. 102). Therefore, the health care staff must emphasize the importance of screening to 




Point-of-care is a device that punctures the lateral edge of the finger pad utilizing a small 
amount of blood to analyze blood serum concentrations. It is a low-cost and convenient 
apparatus used to interpret the cholesterol levels in the body within minutes (Barrett, Huffman, & 
Johnson, 2011). However, Mendez-Gonzalez et al. (2010) questioned the validity of three point- 
of-care devices: Accutrend GCT, Accutrend Plus, and CardioChek. Comparably, the Accutrend 
products proved more reliable than CardioChek: Accutrend Plus yielded 8.5% error, Accutrend 
GCT generated 8.9% error, and CardioChek presented with 25.1% error (Mendez-Gonzalez et 
al., 2010). NCEP guidelines standardized an acceptable margin of error at 9.0%; CardioChek 
failed to meet these guidelines (Mendez-Gonzales et al., 2010). In spite of numerous studies 
supporting the use of Point-of-Care devices, Barrett et al. further stated that although it is an 
acceptable method in determining one's risk for hyperlipidemia, it is not meant to be used as a 
diagnostic tool for a medical condition- a more accurate means of testing should be established 
to verify the results before a diagnosis can be made (Barrett et al., 2011). With comparison, 
Accutrend is the most acceptable point-of-care device for immediate results; however, it is not 
nearly as precise as an automated analyzer (Mendez-Gonzalez et al., 2010). The capabilities of 
point-of-care devices are limited to measuring total cholesterol levels while an automated 
analyzer is able to measure the individual levels of lipoproteins and triglycerides within the 
body. 
Thorton- Miller (2008) emphasized the use of nuclear magnetic resonance (NMR) 
spectroscopy lipoprofiles to analyze the amount of low-density lipoprotein particles as opposed 
to the concentration of cholesterol within each particle.   Small dense low-density lipoproteins 
are capable of passing through the arterial wall, increasing the concentrations in circulation, 




(Thorton-Miller, 2008). Point-of-care devices measure the concentration of low-density 
lipoproteins within the body; however, NMR lipoprofiles measure the particle count within the 
blood stream, making it a more accurate means of testing one's risk for secondary diseases 
(Thorton-Miller, 2008). The avoidance of ingesting food or liquid 9 to 12 hours prior is 
recommended to ensure the greatest reliability from the results (American Heart Association, 
2013a). Moreover, Medicare insures the cost of NMR lipoprofiles (Thorton-Miller, 2008). 
Planning Care 
In order to develop a care plan, the health care provider must differentiate between the 
patient's diagnosis of primary or secondary hyperlipidemia. If there is a defect within the 
patient's genetic deoxyribonucleic acid (DNA) altering the body's ability to naturally balance the 
cholesterol levels, then the patient has primary dyslipidemia, but if the patient developed 
hyperlipidemia secondary to another disease process (i.e. hepatic disease and diabetes), then the 
patient has secondary dyslipidemia (Murphy, 201 l).Once the type of dyslipidemia is determined, 
a plan of action may take place, for in order to treat the disease successfully, the health care 
provider must determine the origin. 
There are several ways to control cholesterol, such as lowering low-density lipoproteins, 
increasing high-density lipoproteins, and maintaining lipoproteins particle counts; however, 
therapy is predominantly directed at lowering low-density lipoprotein levels. All other factors 
are secondary goals (Dembowski & Davidson, 2009). As mentioned previously, low-density 
lipoproteins should be limited to 130 mg/dL or less, and high-density lipoproteins should be 
above 60 mg/dL; however, this is a standardized recommendation for the average person. To 
guide planning for treatment for an individual, his/her lifestyle and risk factors must be taken 
into consideration in order to set a realistic goal for the patient. As the number of risk factors 
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present increase, the patient's life is increasingly threatened. Therefore, the treatment options 
become more rigorous, resulting in a narrow window for the individual's cholesterol goal. 
However, it is also important to monitor treatment options in order to prevent the cholesterol 
concentrations from shifting too far in the other direction. It is critical to remember that 
cholesterol is vital to the daily function of the human body; the goal is to maintain the cholesterol 
concentrations within the normal range. 
Pharmaceutical Interventions 
Medication administration is the method of choice by health care professionals and 
patients in disease management. For hyperlipidemia, health care providers characteristically 
prescribe medications classified as statins. Statins block the function of HMG-CoA within the 
body, thus are classified as HMG-coenzyme A reductase inhibitor. These medications help the 
body absorb excess cholesterol and block the synthesis of cholesterol (Mayo Clinic Staff, 2013). 
McLain and Edlund (2012) reported that, "[With statins,] a 20% to 60% reduction in LDL-C 
levels is achieved, as well as a moderate increase in high-density lipoprotein cholesterol (HDL- 
C) levels of 2% to 16% and a decrease in triglyceride levels of approximately 7% to 37%" (p. 
10). Cholesterol production is at its highest during the night; therefore, researchers have deemed 
statins most effective when taken before bed (McLain, & Edlund, 2012). It is often the treatment 
of choice for moderate or high-risk patients; they are ineffective in low-risk patients 
(Dembowski & Davidson, 2009). Health care professionals should initiate the patient's 
treatment with a low dosage of a statin medication; if it is ineffective, then a greater dose may be 
prescribed in order to achieve the desired low-density lipoproteins level (Ashen & Foody, 2009). 
Forty milligrams of Rosuvastatin (Crestor) proved to be the most effective statin medication 
overall, reducing low-density lipoprotein levels by 63%. Aside from managing cholesterol 
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levels, statins also have anti-inflammatory and plaque prevention properties; new research 
confirms that due to these secondary functions of statin medication, it is associated with a 
decreased risk for Alzheimer's disease and cataracts (McLain, & Edlund, 2012). 
Generic forms of statins are also available for management of hyperlipidemia. The cost 
is approximately four dollars per month and/or offers a co-pay option, making it a low-cost 
method of management (McLain & Edlund, 2012). The effectiveness of generic versions of 
medications is widely disputed among researchers; however, the validity of the generic forms to 
be the brand name equivalent in managing hyperlipidemia is beyond the scope of this essay. 
"A lower achieved LDL in atorvastatin-treated patients was associated with a 16% 
reduction in recurrent CVD events at 24 months after acute coronary syndrome. However, there 
was still a 22.4% recurrent event rate despite an achieved LDL of 62 mg/dL. As clinicians, we 
must be concerned about residual risk, because we do not have complete assurance of plaque 
stabilization even at LDL cholesterol of less than 70 mg/dL" (Braun, 2010, pp. 241- 242). 
Moreover, "The Heart Protection Study (HPS) demonstrated that, in patients with a history of 
coronary artery disease, peripheral vascular disease, diabetes mellitus, hypertension, or other 
vascular disease, 40 mg of simvastatin per day reduced the risk of first stroke" (Schwertz & 
Badellino, 2008, p. 9). No two cases are the same. Therefore, each patient should be assessed as 
an individual rather than generalized as a hyperlipidemic patient. As previously stated, in 
various cases, atorvastatin can prevent a cardiovascular event from recurring, but not every time. 
Therefore, an individual's risks should be analyzed prudently to determine a plan of care that 
will improve patient outcomes. 
For patients with severely high cholesterol levels, a combination of statins and additional 
medications may be used in order to balance cholesterol levels effectively. Furthermore, by 
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reducing cholesterol levels significantly, an individual's risk for an adverse event is reduced 
considerably; therefore, combinations of medications are typically prescribed to have a greater 
impact on the patients' low-density lipoprotein levels. In fact, Braun (2010) reported that 
"combination therapy with niacin and simvastatin produced a 60% to 90% reduction in coronary 
heart disease (CHD) events" (p. 241). Senaratne, Griffiths, MacDonald, and Senaratne (2012) 
discovered that when statins alone have proved ineffective to meet the goal for the low-density 
lipoprotein concentrations, the use of ezetimibe therapy in combination were proven more 
effective; ezetimibe is ineffective in individuals that had a successful response to statin 
medications. Ezetimibe results in a 15% to 25% reduction in low-density lipoproteins (Thorton- 
Miller, 2008). 
Although statins are considered the mainstream drugs for hyperlipidemia, there are 
certain individuals that should avoid this medication. For instance, since statins act on the liver, 
patients with hepatic disease should avoid this medication if possible ("Keys to managing your 
cholesterol", 2012). Alternative medications include bile acid binders, fibrates, and niacin which 
help by preventing cholesterol absorption as well ("Keys to managing your cholesterol", 2012). 
Because of the alterations that statins make within the liver, the health care provider should 
occasionally assess hepatic enzyme levels to prevent drug toxicity and preserve hepatic function 
(Murphy, 2011). In addition to the risk for hepatic impairment, patients may experience a 
memory deficiency- an adverse effect of the medication that should be reported to the health care 
provider immediately (Hudzik, Szkodzinski, & Polonski, 2012). Relatively 10% of the clients 
taking this medication may experience muscle weakness; in severe cases, approximately one 
percent of clients will present with rhabdomylosis, the breakdown of muscular tissue (McLain & 
Edlund, 2012). Hydrophilic statins (e.g. Pravastatin, Rosuvastatin, and Fluvastatin) have a lower 
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risk of causing muscle-related symptoms (McLain & Edlund, 2012). Furthermore, in diabetic 
patients, statin use has been associated with an increase in the HgAic results, a test that measures 
the amount of glucose attached to the hemoglobin (Hudzik, Szkodzinski, & Polonski, 2012). 
Unfortunately, statins also pose a risk for amyotrophic lateral sclerosis, a neurodegenerative 
disease, for it can deprive the muscles of the necessary nutrients to thrive (Samson, 2008). 
Bile Acid Sequestrants are an adequate alternative to statins, which include 
cholestryamine (Questran), colestipol (Colestid), and colesevelam (Welchol). The mechanism of 
action for this medication class is inhibiting the reabsorption of cholesterol into the ileum by 
intercepting the receptor site of bile acid, preventing it from returning to the liver (Murphy, 
2011; Thorton-Miller, 2008). Bile acid sequestrants can reduce low-density lipoprotein 
concentration by 15% to 30% and increase high-density lipoproteins by three to five percent, but 
they also increase triglyceride levels; therefore, these medications should be prescribed with 
extreme caution, and it is recommended to avoid this class of medications if triglyceride levels 
are elevated already in a patient (WebMD, 2010). The patient should take this pharmaceutical 
agent one hour before or five hours after taking other medications (Thorton-Miller, 2008). In 
addition, he/she should remain well hydrated, for this medication may cause bloating and 
constipation (Thorton-Miller, 2008). 
Instead of taking medications, individuals may only want to consider supplements such 
as Niacin and fish oil. Niacin acts on the body by preserving apolipoprotein-Al, thereby 
increasing high-density lipoproteins. While statins lower the low-density lipoproteins, niacin 
significantly increases the quantity of high- density lipoproteins to carry the low-density 
lipoproteins out of the body, having a profound effect in reducing an individual's risk (Mayo 




diffuse into the blood stream; in result, the blood serum concentrations of low-density 
lipoproteins are reduced by 10% to 15% (Thorton-Miller, 2008). The health care provider 
should carefully prescribe and monitor niacin, for excessive consumption can lead to gout and 
liver damage (Dudek, 2010). Fish oil, a supplement containing high levels of omega- 3 fatty 
acids, has been proven to reduce triglyceride levels by decreasing the synthesis of cholesterol in 
the liver (Hessel, 2010). Fish oil dilutes the blood; therefore, individuals taking anticoagulants 
should consult their doctor before using to avoid bleeding complications (Dudek, 2010). Hessel 
(2010) conducted a study analyzing the effects of Lovaza, a brand offish oil, on cholesterol 
levels. Hessel (2010) concluded that, "Lovaza produced a 20% reduction in total cholesterol, a 
13% increase in HDL cholesterol levels, and a 32% reduction in VLDL cholesterol levels" (p. 
225). A daily dose between two to four grams is recommended; however, fish oil is 
contraindicated in children, pregnant women, and women that are breast-feeding (Hessel, 2010). 
Although aspirin, acetylsalicylic acid, has no effect on cholesterol levels, some, 
especially high-risk individuals, may benefit from this medication. Aspirin is classified as a non- 
steroidal anti-inflammatory drug (NSAID); most commonly known as a "blood thinner". For 
individuals at high risk, this agent will allow the blood to flow smoothly, decreasing the risk for 
a blood clot if atherosclerotic plaque is present (Caboral, 2013). Because the blood is thinner, 
the vessels are not easily congested, reducing the incidence of clot formation and plaque 
detachment. 
Regardless of the medications prescribed to the patient, educating about the medication 
and emphasizing the importance of adhering to medication regimen is crucial to sustaining its 
beneficial effects on cholesterol. After one year, it is estimated that approximately 40% of 




discover the cause of noncompliance with the medication program and to explore other suitable 
options for the patient. In addition, although medicine can do wonders, it is necessary to educate 
the client about non-pharmaceutical interventions as well, since medication is not always a cure 
for a condition. Medications simply manipulate the body to mimic a healthy one. On the 
contrary, in a cooperative patient, non-pharmaceutical methods can serve as a cure, for they 
typically attack the etiology. 
Non-pharmaceutical Interventions 
Seventy-five percent of cholesterol is maintained through the body in the blood, liver, 
and other cells; the remaining 25% is defined by the patient's diet (American Heart Association, 
2012b). When treating a patient, many health care providers will emphasize dietary concerns in 
relation to cholesterol. 
Overall, dietary cholesterol should be limited to 200 milligrams per day (mg/day) -the 
equivalent to the weight of a one-carat diamond (Woods, 2010). Dietary cholesterol is only 
available in animal products; it is not plant-based (Dudek, 2010). Therefore, it is important for 
vegetarians and vegans to find an acceptable source of dietary cholesterol to meet the body's 
daily requirement. Eating a low fat and/or Mediterranean diet can further promote a reduction in 
low-density lipoproteins and increase in high-density lipoproteins (Dudek, 2010). 
Carbohydrates should be less than 45% of your daily intake to help decrease triglyceride 
levels (American Heart Association, 2013a). The body produces sufficient amounts of saturated 
fat to meet the daily requirements; therefore, the consumption of additional saturated fat is 
unnecessary and potentially hazardous to the blood vessels (Murphy, 2011). Saturated fat can be 
limited by consuming lean meats, low-fat dairy products, and avoiding fast food (Murphy, 2011). 
Unsaturated fat is the best alternative for fat consumption. Unsaturated fats include olive oil, 
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canola oil, peanut oil, avocado, cashews, almonds, corn, soybean, safflower, cottonseeds oil, and 
fish (Dudek, 2010). 
Foods such as red meat and egg yolks result in an imbalance of cholesterol levels. 
However, it is also "important to remember that eggs are good sources of the carotenoids, lutein 
and zeaxanthin, that have been shown to prevent macular degeneration and LDL oxidation and 
of choline, an essential nutrient for fetal development" (Fernandez, 2012, p. 120). Therefore, the 
health care provider should consider the benefits of eggs versus the risks. Soy protein may act as 
a dairy substitute, for it has been proven to reduce low-density lipoprotein levels by 25 
grams/day (Dudek, 2010). Breast milk has high cholesterol content; the high levels are believed 
to expose the child early on so that he may develop a control mechanism to manage cholesterol 
throughout life (Dudek, 2010). 
Increasing fiber to about 25 grams per day can help reduce low-density lipoprotein 
concentration and particle count as well; high fiber foods include fruits, vegetables, whole grains, 
beans, and seeds (Thorton-Miller 2008; Woods, 2010). "People who eat three or more servings 
of whole grains daily have 20% to 30% lower risk of atherosclerotic cardiovascular disease" 
(Dudek, 2010, p. 33). Small traces of sterols are found in high fiber foods as well. Plant sterols 
and stanol esters inhibit the absorption of cholesterol and prevent the body from converting it 
into a usable form; these actions cause a reduction in low-density lipoproteins (Jones & 
AbuMweis, 2009). Ingesting approximately, two grams of plant sterols per day can result in a 
7.5 to 11.6% reduction in low-density lipoproteins (Jones & AbuMweis, 2009). A few examples 
of products containing a high percentage of sterols are psyllium, eggplant, okra, and oats ("Keys 
to manage", 2012). Due to increased demand in the produce market, individuals now may buy 
specifically sterol-fortified foods, such as orange juice and cereal (Griffin, 2012). However, 
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plant sterols have the capability to reduce the effectiveness of fat-soluble vitamins by inhibiting 
absorption into the body- beta-carotene by 25%, alpha-carotene by ten percent, and vitamin E by 
eight percent (Jones & AbuMweis, 2009). 
Foods that are broiled, grilled, or baked are strongly encouraged for their positive effects 
on cholesterol levels as well (Griffin, 2012). Murphy (2011) stated that "eliminating Trans fats 
from the diet can decrease the risk of cardiovascular disease up to 19%" (p. 30). On the opposing 
spectrum, because of the high content of low-density lipoproteins, salad dressings and 
mayonnaise should be limited in the diet (Murphy, 2011). Avoiding foods high in trans-fat such 
as margarine and fried foods is also recommended, for they can cause an increase in low-density 
lipoproteins while decreasing high-density lipoproteins; this results in fatty deposits within 
vessels ("Is 'good' cholesterol still good for you?", 2012). Additionally, a clove of garlic per 
day is associated with decreased low-density lipoprotein levels (Dudek, 2010). 
According to the Centers of Disease Control and Prevention, one out of three adults and 
one out of six children are classified as obese, a major risk factor for high cholesterol (2011). 
Low activity has likely contributed to the growth in obesity in the United States. In fact, 
Williams (2008) stated "41% percent of women and 35% of men engaged in no leisure-time 
physical activity, and 73% of women and 66% of men are inadequately active" (p. 433). 
"Approximately 60% of overweight American children also have hypertension, 
hyperinsulinaemia, and/or hyperlipidemia" (Barrett, Huffman, & Johnson, 2011, p. 52). Rather 
than encouraging these children to take cholesterol medication, regular physical exercise should 
be encouraged as a healthier method to manage cholesterol levels. 
Exercise is a means of primary and secondary prevention; it can prevent hyperlipidemia 
and reverse hyperlipidemia in its early stages (Lavie, Church, Milani, & Earnest, 2011). In 
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general, weight loss can promote a reduction in low-density lipoproteins: losing 10 pounds can 
reduce the low-density lipoprotein count by approximately seven milligrams per deciliter (Braun, 
2010). Furthermore, losing 20 pounds can reduce the low-density lipoprotein particle count by 
50% (Thorton-Miller, 2008). Beyond its effects on low-density lipoproteins, weight loss can 
also promote a lower blood pressure, lower blood sugar, and most importantly, an increase in 
high-density lipoproteins to rid the body of excess low-density lipoproteins ("Is 'good' 
cholesterol still good for you?", 2012). The author of Mayo Clinic Staff (2013) recommended 
exercising for 30 minutes, five days a week to reduce the low-density lipoprotein concentration 
efficiently. As stamina develops, one should increase the length of their exercise routine to 40 
minutes at least four days of the week (Murphy, 2011). Thorton-Miller (2008) reported that with 
continuous exercise, patients' low-density lipoprotein particle count dropped by 62%, while the 
high-density lipoproteins increased by 11%. Conversely, United States society emphasizes rapid 
weight loss plans, but it fails to encourage a healthy weight loss plan; therefore, the health care 
provider should educate the patient about the hazards of losing too much weight too suddenly. 
Researchers have shown that the intensity of exercises does not affect cholesterol levels 
as positively as the frequency of exercising (Thorton-Miller, 2008). Some patients squirm at the 
thought of exercising. For these individuals, it is imperative to offer alternatives such as taking 
the stairs instead of the elevator or parking further away from the entrance of a building; any 
exercise is better than no exercise. However, before beginning exercise, it is crucial to speak to a 
healthcare provider before performing any strenuous activity to ensure patient safety. 
Smoking habits and alcohol consumption may influence cholesterol levels as well. In 
fact, the cessation of smoking can increase the amount of high-density lipoproteins in the body, 
allowing for increased transport of low-density lipoproteins out of the body ("Is 'good' 
MMmmmmmmmmmm 
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cholesterol still good for you?", 2012). Secondhand smoke can also cause an increase in low- 
density lipoprotein levels (Woods, 2010). Alcohol has no particular benefit to lowering low- 
density lipoproteins. However, if an individual is an alcohol drinker, alcohol should be limited 
to one or two drinks per day, in order to maintain a healthy high-density lipoprotein levels ("Is 
'good' cholesterol still good for you?" 2012). According to Thorton-Miller (2008), one 
alcoholic drink is defined as one and a half ounces of hard liquor, five ounces of wine, or 12 
ounces of beer. Although alcohol has proven to have beneficial effects to high-density 
lipoprotein levels, it is a situation to weigh benefits versus risks. "Alcohol can be addictive, and 
high intakes are associated with high triglyceride levels, hypertension, liver damage, physical 
abuse, vehicular and work accidents, and increased risk of breast cancer" (Dudek, 2010, p. 
498). 
Health Promotion 
In order for a change in health behavior to occur, the individual must have confidence 
that the change can occur.   Often, individuals believe that there is a lack of time, knowledge, or 
motivation for a change to transpire in their lives; therefore, health care providers must actively 
promote a transtheoretical approach to overcome these barriers to meet each individual's need 
(Peterson, 2012). The Health Belief Model (HBM) states that, "the degree to which a person 
engages in health promotion activities depends on the perceived benefits of healthy behaviors 
related to the perceived threat of not engaging in preventive behaviors" (Peterson, 2012, p. 297). 
Although this has not been an effective tool with all samples, it is helpful to a few samples, 
making it a valuable tool to consider in promoting secondary or tertiary prevention (Peterson, 
2012). Going beyond the disease process, the Health Promotion Model emphasizes the positive 
role that self- improvement plays in health behavior change. Peterson (2012) found that in older 
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women, the thought of lifting their spirits and improving their sense of well-being increased the 
number willing to participate in physical activity. Health care providers must talk with their 
patients to discuss any fears or concerns that they may have with changing health behaviors and 
to discuss ways to overcome these barriers, regardless of whether or not they can alter their 
health behavior (Peterson, 2012). If the individual perceives that he/she cannot, then the 
individual will not (Peterson, 2012). 
The Social Cognitive Theory (SCT) targets interpersonal relationships (e.g. support 
person, peer pressure, and media) to improve compliance (Peterson, 2012). In fact, Johansson et 
al. (2012) associated the increase of hyperlipidemia in Sweden with the promotion in media for a 
low carbohydrate- high fat diet, demonstrating the impact media has on the population health 
trends. Furthermore, the SCT emphasizes the use of persuasion by encouraging independence in 
care and developing goals (Peterson, 2012). Thorton-Miller (2008) suggested that patients 
record their meals for one week then return to the health care provider to review the record. The 
health care provider should not criticize the unhealthy food product consumed, as it will 
discourage the patient, but rather identify the positive aspects and review the components of a 
nutritious diet (Thorton-Miller, 2008). 
Social and environmental factors may also influence health behaviors. The health care 
provider must ensure that the recommendations she or he provides correlate with what the 
individual is capable of completing. If there is no grocery store nearby selling fruits and 
vegetables or the individual cannot afford to purchase these items, the client will be 
noncompliant to care plan that identifies the need to increase the nutrient value within the diet; 
therefore, outside resources must be identified and readily available to the client (Peterson, 




patient is not consuming a healthy diet due to poverty, then meals on wheels may be an option. 
Locally, Meals on Wheels is on 1500 Second Avenue in Columbus, Georgia, and extends their 
services to the surrounding area. For individuals that may be struggling to pay for health care 
and/or may refuse to seek medical treatment because of financial circumstances, there are several 
income-based health care services offered locally, such as Valley Health Care and Mercy Med. 
Furthermore, public transportation is offered throughout town. The homeless resource network 
is located on 2221 Second Avenue in Columbus, Georgia for those that need a place to stay, 
improving sanitation and overall health. Valley Rescue Mission provides several options for 
impoverished individuals. These are a few of the resources that Columbus has to offer to alter 
social and environmental circumstances; several more options should be explored to meet the 
patient's needs. If the patient is poverty stricken, then compliance is typically minimal. The 
patient will not buy healthy food products or buy medications if he or she is unable to afford 
housing. In order for continuity of care to occur, then resources outside the hospital must be 
identified for the client. 
Is Hyperlipidemia Life Threatening for Every Patient? 
Hyperlipidemia can be beneficial to a minority of the population. A few conditions 
warrant the need for high cholesterol levels in order to improve the health of a client. Samson 
(2008) testified that individuals with amyotrophic lateral sclerosis (ALS) suffer with 
hypermetabolism; in result, they are often weak and malnourished. Hypercholestremia can 
prolong life in these patients by approximately one year (Samson, 2008). 
Although an imbalance in cholesterol levels can have detrimental effects on men and 
women, elevated levels of low-density lipoproteins in children should not be alarming, for 




where children have been reported to have exceedingly high levels of low-density lipoproteins, 
greater than 160 mg/dL (Potera, 2010). Nonetheless, it is recommended to wait at least three 
years before considering treatment options, for upon re-examination, many children will show a 
vast decrease in these levels; therefore, treatment is not usually necessary (Potera, 2010). 
Although these children may not require treatment, they must be monitored closely throughout 
adulthood to ensure that hyperlipidemia does not develop and progress into other complications 
(Potera, 2010). 
In a few situations, there are individuals with severe hyperlipidemia that present with no 
chronic illness. For instance, a patient can test with elevated levels of low-density lipoprotein 
concentrations, but they may have a depressed low-density lipoprotein count. Therefore, 
although the low-density lipoproteins are carrying large concentrations of cholesterol, they are 
not passing into the blood stream because of their size. Thus, the typical cholesterol tests may 
illustrate an elevation in concentrations within the body; however, the number of particles within 
the bloodstream, not the concentrations, is the most hazardous. 
Conclusion 
Millions of dollars are invested each year into controlling the incidence and prevalence of 
hyperlipidemia; nevertheless, hyperlipidemia remains prevalent worldwide. To assist in 
decreasing the pervasiveness of this disease, an increase in health literacy in the population, 
access to health resources in the community, and the patients' willingness to alter lifestyle 
behaviors must be present and emphasized by health care professionals and the media. 
Individuals need to be screened for hypercholestremia every five years if no risks factors are 
present; they should be screened every year if a risk factor is present. Although statins and other 
cholesterol-lowering medications and supplements are deemed effective methods for treatment, 
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they are not a cure and should be used with extreme caution in patients with hepatic disease, 
renal disease, and alcoholism. Non-pharmacological approaches to treatment include, but are not 
limited to, weight loss, dietary changes, and smoking cessation. Before making any changes to 
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